Valiant Laboratories Stock Price - ₹140.75 | Healthcare | askfuzz

Sign in to fuzzto save your conversations, follow your research and come back anytime.

‌

‌
‌

‌
‌
‌

‌
‌
‌
‌
‌
‌

Valiant Laboratories Stock Price - ₹140.75 | Healthcare | askfuzz

Quarterly Results

₹Cr

Metric (₹ crore)	Q1 FY23	Q3 FY23	Q4 FY23	Q1 FY24	Q2 FY24	Q3 FY24	Q4 FY24	Q1 FY25	Q2 FY25	Q3 FY25	Q4 FY25	Q1 FY26	Q2 FY26	Q3 FY26	Q4 FY26	Q1 FY27
Sales	83.91	70.77	89.92	51.41	59.55	40.52	30.59	18.88	21.48	35.23	57.79	46.82	46.2	52.46	91.98	115.29
Expenses	79.36	60.85	81.31	47.59	60.93	46.82	35.12	21.27	28.22	34.61	53.96	44.42	46.12	53.35	87.17	86.03
EBITDA	4.55	9.92	8.61	3.82	-1.38	-6.3	-4.53	-2.39	-6.74	0.62	3.83	2.4	0.08	-0.89	4.81	29.26
Depreciation	0.35	0.4	0.44	0.46	0.49	0.49	0.52	0.53	0.52	0.52	0.52	0.53	0.53	2.05	2.93	2.86
EBIT	4.2	9.52	8.17	3.36	-1.87	-6.79	-5.05	-2.92	-7.26	0.1	3.31	1.87	-0.45	-2.94	1.88	26.4
Interest	0.02	0.04	0.03	0.02	0.02	0.02	0.02	0.05	0.01	0.06	0.05	0.07	0.14	0.68	1.01	1.07
Profit Before Tax	4.18	9.48	8.14	3.34	-1.89	-6.81	-5.07	-2.97	-7.27	0.04	3.26	1.8	-0.59	-3.62	0.87	25.33
Net Profit	2.69	7.65	7.83	4.27	0.79	-3.5	-1.24	-0.51	-4.74	2.35	0.7	1.82	0.2	-7.06	1.76	21.1
EPS	1.65	4.7	2.41	1.31	0.24	-0.81	-0.33	-0.13	-1.09	0.54	0.16	0.42	0.04	-1.3	0.32	3.89

Cashflow

₹Cr

Metric (₹ crore)	FY23	FY24	FY25	FY26
Operating Cash Flow	56.05	1.89	1.31	-10.43
Investing Cash Flow	-55.17	-143.88	-52.77	7.25
Financing Cash Flow	-0.93	152.45	44.65	1.79
Net Cash Flow	-0.05	10.46	-6.81	-1.39

Balance Sheet

Annual

₹Cr

Metric (₹ crore)	FY23	FY24	FY25	FY26
Equity / Shareholders' Funds	100.49	236.86	234.31	310.88
Total Liabilities	112.47	105.83	166.55	153.09
Total Assets	212.97	342.69	400.86	463.98

Shareholding

₹731 CrMarket Cap

Promoter & promoter group (74.94%)

Public & others (24.91%)